- Type / Class
- Equity / Common Stock
- Shares outstanding
- 235,704,040
- Total 13F shares
- 8,422,364
- Share change
- -61,076
- Total reported value
- $67,999,000
- Price per share
- $8.07
- Number of holders
- 24
- Value change
- -$508,297
- Number of buys
- 11
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 000899104?
CUSIP 000899104 identifies ADMA - ADMA BIOLOGICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 000899104:
Top shareholders of ADMA - ADMA BIOLOGICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Aisling Capital LLC |
13F
|
Company |
1.5%
|
3,608,171
|
$30,164,000 | — | 30 Sep 2015 | |
| Consonance Capital Management LP |
13F
|
Company |
0.45%
|
1,052,142
|
$8,796,000 | — | 30 Sep 2015 | |
| Broadfin Capital, LLC |
13F
|
Company |
0.41%
|
964,193
|
$8,061,000 | — | 30 Sep 2015 | |
| FMR LLC |
13F
|
Company |
0.18%
|
423,100
|
$3,537,000 | — | 30 Sep 2015 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.11%
|
264,099
|
$2,208,000 | — | 30 Sep 2015 | |
| PointState Capital LP |
13F
|
Company |
0.09%
|
203,158
|
$1,698,000 | — | 30 Sep 2015 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.07%
|
154,000
|
$1,287,000 | — | 30 Sep 2015 | |
| J. Goldman & Co LP |
13F
|
Company |
0.05%
|
121,756
|
$1,018,000 | — | 30 Sep 2015 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.02%
|
55,943
|
$468,000 | — | 30 Sep 2015 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.02%
|
46,987
|
$393,000 | — | 30 Sep 2015 | |
| COMMERZBANK AKTIENGESELLSCHAFT /FI |
13F
|
Company |
0.02%
|
39,086
|
$327,000 | — | 30 Sep 2015 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.02%
|
36,400
|
$304,000 | — | 30 Sep 2015 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.01%
|
24,035
|
$201,000 | — | 30 Sep 2015 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.01%
|
18,319
|
$153,000 | — | 30 Sep 2015 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
13,635
|
$114,000 | — | 30 Sep 2015 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
11,000
|
$92,000 | — | 30 Sep 2015 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
6,152
|
$52,000 | — | 30 Sep 2015 | |
| Mount Lucas Management LP |
13F
|
Company |
0%
|
2,500
|
$21,000 | — | 30 Sep 2015 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
2,005
|
$17,000 | — | 30 Sep 2015 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,000
|
$17,000 | — | 30 Sep 2015 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
619
|
$6,000 | — | 30 Sep 2015 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
608
|
$5,000 | — | 30 Sep 2015 | |
| Endurance Wealth Management, Inc. |
13F
|
Company |
0%
|
300
|
$3,000 | — | 30 Sep 2015 |
Institutional Holders of ADMA BIOLOGICS, INC. - Common Stock (ADMA) as of Q4 2015
As of 31 Dec 2015,
ADMA BIOLOGICS, INC. - Common Stock (ADMA) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,422,364 shares.
The largest 10 holders included
Aisling Capital LLC, Biomark Capital Management Co. LLC, Consonance Capital Management LP, Broadfin Capital, LLC, FMR LLC, FRANKLIN RESOURCES INC, PointState Capital LP, Weiss Multi-Strategy Advisers LLC, J. Goldman & Co LP, and Telemetry Investments, L.L.C..
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2015 vs Q3 2015 Across Filers
Q3 2015 holders
23
Q4 2015 holders
24
Holder diff
1
| Investor | Q3 2015 Shares | Q4 2015 Shares | Share Diff | Share Chg % | Q3 2015 Value $ | Q4 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.